Abstract
Stroke is a prevalent and disabling disease, whose care in Brazil is insufficient and concentrated in a few centers of high complexity. Among the types of stroke, 80 to 85% are of ischemic etiology, and the only treatment currently available in the hyperacute phase of ischemic stroke with proven impact on the functional outcome is the use of intravenous thrombolytic therapy within 4.5 hou…